FBIO

Fortress Biotech, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-31

Figures on this page computed 2026-11-08 12:40 UTC

Last close

1.97USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-31

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
The filing itself
10.8%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.37 against 0.52 on the market's range.

What it sells, to whom

lens 8 of 9

What it sells

Journey61,858,000 UNIT_STAND97.8%

Avenue Therapeutics, Inc1,404,000 UNIT_STAND2.2%

Checkpointn/a

Mustangn/a

Fortress Biotech Incn/a

Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.

5 segments, 0 places and 0 named customers, each as the filer published it.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-31

Journey61,858,000
Source
filed
Statement
segments
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
UNIT_STAND
The filing itself
Avenue Therapeutics, Inc1,404,000
Source
filed
Statement
segments
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
UNIT_STAND
The filing itself
Checkpointn/a
Not held.
Source
filed
Statement
segments
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
UNIT_STAND
The filing itself
Mustangn/a
Not held.
Source
filed
Statement
segments
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
UNIT_STAND
The filing itself
Fortress Biotech Incn/a
Not held.
Source
filed
Statement
segments
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
UNIT_STAND
The filing itself